Shanghai Pharma eyes big Celesio stake; Mylan expects 2011 sales to top $6B;

@FiercePharma: Abbott merges U.S., foreign pharma units under new chief. Item | Follow @FiercePharma

> Shanghai Pharmaceutical is close to acquiring a large stake in drug distributor Celesio from major shareholder Haniel, German paper Handelsblatt reported, citing financial sources. News

> Mylan posted higher quarterly earnings from operations, matching analysts' estimates, and forecast 2011 profit in line with Wall Street expectations. Report

> Bristol-Myers Squibb and AstraZeneca said they are expanding the label of their diabetes drug Onglyza, adding information about the drug's effects in patients with kidney failure. News

> Danish drugmaker Lundbeck warned of major lost sales of its antidepressant treatment Lexapro in coming years due to generic competition, including a large part of its $450 million annual U.S. sales. Item

> Genentech allegedly colluded with Celltech R&D to fraudulently extend the life of a disputed patent and reaped more than a $1 billion in royalties, according to a lawsuit by rival drugmaker Human Genome Sciences. Report

> Questcor Pharmaceuticals posted fourth-quarter financial results that fell short of Wall Street projections. Article

> GlaxoSmithKline has received the 2010 Environmental Stewardship Award from Nalco Company in recognition of its ongoing efforts to reduce its climate change impact and energy and water use. GSK release

Biotech News

@FierceBiotech: Billionaire biotech investor touts his next Big Thing. Story | Follow @FierceBiotech

@JohnCFierce: In case you missed it: Pharming plans Phase IIIB on Rhucin, anticipating the FDA will ask for more data. That's proactive. News | Follow @JohnCFierce 

> Chinese CRO attracts $40M, powerful connection in venture round. Report

> Pfizer's crizotinib eliminates signs of advanced lymphoma. News

> NicOx plans long-shot appeal of FDA's naproxcinod rejection. Story 

> Sanofi's dilemma: Keeping R&D talent from bolting Genzyme. Item 

> R&D realignment prompts Roche to dump Transgene HPV pact. Report 

Vaccines News

> Emory researchers find long-lasting vax immunity via yellow fever. Story 

> Boston vaccinates against possible measles outbreak. Item 

> "Dirty" bacteria could become asthma vax. News 

> Roche pulls out of Transgene vaccine pact. Story 

> Supreme Court: Drugmakers can't be sued for defective vaccine. Report

Manufacturing News

> India waffles on vax plant (again). Story

> Labeling mishaps spark separate recalls. News

> HHS aims high in vax plan. Article

> Find track/trace baseline before choosing tech. Item 

> FDA rejects Sanofi contaminant sampling method. Story 

> New J&J recalls hint at far-reaching QA woes. Report

And Finally... A groundbreaking plaintiffs' attorney should be disbarred for bilking clients out of millions of dollars in the settlement of a 1998 diet-pill lawsuit, a Kentucky judicial official said. Story

Suggested Articles

Six pharmaceutical execs are set to head to Washington next week for pricing hearings at the House Committee on Oversight and Reform. 

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Biogen is giving former chief finance officer Jeff Capello a multimillion-dollar cash payment plus other severance benefits.